IP Library › Patent Application 13232410
Patent Application
App. No. 13/232,410

USE OF INHIBITORS OF JUN N-TERMINAL KINASES TO TREAT GLAUCOMA

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/232,410
Abstract

Compositions and methods for lowering IOP and/or providing neuroprotection are disclosed. The compositions and methods are particularly directed to the use inhibitors of Jun N-terminal kinases (JNK) to lower IOP and/or provide neuroprotection.

Claims (3)

1 . A method for providing neuroprotection in an eye of a human patient identified as having glaucoma, said method comprising administering to the human patient a composition comprising a therapeutically effective amount of 2H-Dibenzo[cd,g]indazol-6-one (SP600125).

2 . A method according to claim 1 , wherein the composition is an oral formulation.

3 . A method according to claim 1 , wherein the composition is a topical ophthalmic, surgical irrigating solution or an intraocular formulation.